By Karl Simpson (auth.), Bernardo Sorj, Mark Cantley, Karl Simpson (eds.)
The accession of Spain and Portugal to club of the eu group in January 1985 not just introduced new energy to the ecu initiative, yet served as a robust reminder of the wider dimensions of the Spanish- and Portuguese-speaking worlds. A reinforcement of Europe's usual and historic interna tionalism of outlook used to be relatively correct within the context of biotechnology; for the subtle multi-disciplinary clinical base, and the different large program parts, strength on biotechnol ogy an internationalism either for entry to medical strength, and for entry to world wide markets. Such used to be the explanation for 'SOBELA': a 'Seminar on Biotechnol ogy in Europe and Latin America', which in April 1987 introduced a few 50 Latin American marketers, policy-makers and educational leaders to Europe and to Brussels. on the Commission's Borschette convention Centre, they heard shows from 11 of the neighborhood Member States, each one emphasising its strengths in bio expertise and its curiosity in selling commercial collaboration with organisations in Latin the US. The seminar was once opened through speeches from Vice-President Karl Heinz Narjes on behalf of the fee, and by way of His Excellency Luis Ramiro Alfonsin of Argentina, senior Latin American diplomat in Brussels. within the final consultation, Directors-General Paolo Fasella (Science, learn and improvement, DG XII) and Jean Durieux (External kin, DG I) welcomed Their Excellencies the ambas sadors from Argentina, Mexico, Brazil, Uruguay and Colombia.